Faculty Members

Dr.Ziyad Saeed M Almalki

Associate Professor Department of Clinical Pharmacy College of Pharmacy AL-Kharj

Kharj
011-588-6059
z.almalki@psau.edu.sa

Curriculum Vitae
Publications

Education

2008 Bachelor's Degree: Pharmacy College of Pharmacy, King Saud University
2017 Doctor of Philosophy: Health Economics The James L. Winkle College of Pharmacy, University of Cincinnati

Research Interests

Health Economics, Evidence-Synthesis, Decision Analysis in Healthcare, Economic Evaluation, Prediction Models for Economic Evaluation, Drug Utilization Reviews, Healthcare service Utilization and Cost Analyses, Health Technology Assessment, Clinical Practice, Medication Use and Pharmacovigilance, Healthcare Policy and Quality Improvement, Health System Performance, Health Services Management, Patient Safety, And Clinical Risk Management, Formulary Management.

Experience

2019 - until now - Member in the National Health Economics Advisory Committee - Saudi Health Council
2020 - until now - Member in the Pharmaceutical Products Pricing Committee - Saudi Food and Drug Authority (FDA)
2019 - until now - Head of Clinical Pharmacy Department - Prince Sattam Bin Abdulaziz University
2017 - until now - Assistant Professor - Prince Sattam Bin Abdulaziz University

Publications

1. Ahmad, Niyaz, Mohammed Jameel Abdulrahman Al-Ghamdi, Hani Saleh M. Alnajjad, Basaam Basim A. Al Omar, Mohd Faiyaz Khan, Ziyad Saeed Almalki, Ahmed A. Albassam, Zabih Ullah, Mohammed Saifuddin Khalid, and Kamran Ashraf. "A comparative brain Toxico-Pharmacokinetics study of a developed tannic acid nanoparticles in the treatment of epilepsy." Journal of Drug Delivery Science and Technology (2022): 103772.
2. Almalki, Ziyad S., Abdullah K. Alahmari, Ahmed M. Alshehri, Abdulaziz Altowaijri, Mohammed Alluhidan, Nehad Ahmed, Abdulhakim S. AlAbdulsalam et al. "Investigating households’ out-of-pocket healthcare expenditures based on number of chronic conditions in Riyadh, Saudi Arabia: a cross-sectional study using quantile regression approach." BMJ open 12, no. 9 (2022): e066145.
3. Alrashed A, Cahusac P, Mohzari YA, Bamogaddam RF, Alfaifi M, Mathew M, Alrumayyan BF, Alqahtani BF, Alshammari A, AlNekhilan K, Binrokan A, Alamri K, Alshahrani A, Alshahrani S, Alanazi AS, Alhassan BM, Alsaeed A, Almutairi W, Albujaidy A, AlJuaid L, Almalki ZS, Ahmed N, Alajami HN, Aljishi HM, Alsheef M, Alajlan SA, Almutairi F, Alsirhani A, Alotaibi M, Aljaber MA, Bahammam HA, Aldandan H, Almulhim AS, Abraham I, Alamer A." Frontiers in cardiovascular medicine (2022): 2119.
4. Almalki, Ziyad S., Abdullah K. Alahmari, Nasser Alqahtani, Abdulaziz Ibrahim Alzarea, Ahmed M. Alshehri, Abdulrahman M. Alruwaybiah, Bader A. Alanazi, Abdulhadi M. Alqahtani, and Nehad J. Ahmed. "Households’ Direct Economic Burden Associated with Chronic Non-Communicable Diseases in Saudi Arabia." International Journal of Environmental Research and Public Health 19, no. 15 (2022): 9736.
5. Al-Ahmari, Abdullah K., Amnah AlAsmari, Anoud AlKorbi, Nehad J. Ahmed, Ziyad S. Almalki, Ahmed M. Alshehri, Ahmed A. Albassam, and Ghada M. Alem. "Comparison of the post-marketing safety profile between influenza and COVID-19 vaccines: An analysis of the vaccine adverse event reporting system." Saudi Pharmaceutical Journal 30, no. 8 (2022): 1137-1142.
6. Fayed, Mohamed H., Ahmed Alalaiwe, Ziyad S. Almalki, and Doaa A. Helal. "Design space approach for the optimization of green fluidized bed granulation process in the granulation of a poorly water-soluble fenofibrate using design of experiment." Pharmaceutics 14, no. 7 (2022): 1471.
7. Balaha, Mohamed F., Ziyad S. Almalki, Abdullah K. Alahmari, Nehad J. Ahmed, and Marwa F. Balaha. "AMPK/mTOR-driven autophagy & Nrf2/HO-1 cascade modulation by amentoflavone ameliorates indomethacin-induced‎ gastric‎ ulcer." Biomedicine & Pharmacotherapy 151 (2022): 113200.
8. Alzarea, Abdulaziz Ibrahim, Yusra Habib Khan, Abdullah Salah Alanazi, Muhammad Hammad Butt, Ziyad Saeed Almalki, Abdullah K. AlAhmari, Saud Alsahali, and Tauqeer Hussain Mallhi. "Barriers and Facilitators of Pharmacoeconomic Studies: A Review of Evidence from the Middle Eastern Countries." International Journal of Environmental Research and Public Health 19, no. 13 (2022): 7862.
9. Alahmari, Abdullah K., Ziyad S. Almalki, Ahmed A. Albassam, Mohammed M. Alsultan, Ahmed M. Alshehri, Nehad J. Ahmed, and Abdulhadi M. Alqahtani. "Factors Associated with Length of Hospital Stay among COVID-19 Patients in Saudi Arabia: A Retrospective Study during the First Pandemic Wave." In Healthcare, vol. 10, no. 7, p. 1201. MDPI, 2022.
10. Alzarea, Abdulaziz Ibrahim, Yusra Habib Khan, Ahmed D. Alatawi, Abdullah Salah Alanazi, Sami I. Alzarea, Muhammad Hammad Butt, Ziyad Saeed Almalki, Abdullah K. Alahmari, and Tauqeer Hussain Mallhi. "Surveillance of Post-Vaccination Side Effects of COVID-19 Vaccines among Saudi Population: A Real-World Estimation of Safety Profile." Vaccines 10, no. 6 (2022): 924.
11. Balaha, Mohamed F., Nehad J. Ahmed, Ziyad S. Almalki, Abdullah K. Alahmari, Ahmed M. Alshehri, Gamal A. Soliman, and Abubaker M. Hamad. "Epimedin A ameliorates DNFB-induced allergic contact dermatitis in mice: Role of NF-κB/NLRP3-driven pyroptosis, Nrf2/HO-1 pathway, and inflammation modulation." Life Sciences (2022): 120653.
12. Malkin, J.D., Baid, D., Alsukait, R.F., Alghaith, T., Alluhidan, M., Alabdulkarim, H., Altowaijri, A., Almalki, Z.S., Herbst, C.H., Finkelstein, E.A. and El-Saharty, S., 2022. The economic burden of overweight and obesity in Saudi Arabia. Plos one, 17(3), p.e0264993.
13. Alzarea AI, Alruwaili NK, Ahmad MM, Munir MU, Butt AM, Alrowaili ZA, Shahari MSB, Almalki ZS, Alqahtani SS, Dolzhenko AV, Ahmad N. Development and Characterization of Gentamicin-Loaded Arabinoxylan-Sodium Alginate Films as Antibacterial Wound Dressing. Int J Mol Sci. 2022;23(5):2899.
14. Ahmed, Nehad J., Ziyad S. Almalki, Abdullah A. Alfaifi, Ahmed M. Alshehri, Abdullah K. Alahmari, Emad Elazab, Alaa Almansour, Abdul Haseeb, Mohamed F. Balaha, and Amer H. Khan. "Implementing an Antimicrobial Stewardship Programme to Improve Adherence to a Perioperative Prophylaxis Guideline." In Healthcare, vol. 10, no. 3, p. 464. MDPI, 2022.
15. Ahmed, Nehad J., Abdullah K. Alahmari, Ahmed M. Alshehri, and Ziyad S. Almalki. "Dalfampridine Associated Serious Adverse Events: An Analysis of Data from the Food and Drug Administration's Adverse Event Reporting System." LATIN AMERICAN JOURNAL OF PHARMACY 41, no. 6 (2022): 1195-1199.
16. Almalki, Ziyad S., Bedor Abdullah AlOmari, Tahani Alshammari, Areej Alshlowi, Mohd Faiyaz Khan, Ali Hazazi, Maha Alruwaily et al. "Uncontrolled blood pressure among hypertensive adults with rheumatoid arthritis in Saudi Arabia: A cross-sectional study." Medicine 101, no. 4 (2022).
17. Alshehri, Ahmed M., Lara A. Elsawaf, Shaikah F. Alzaid, Yasser S. Almogbel, Mohammed A. Alminggash, Ziyad S. Almalki, and Majed A. Algarni. "Factors Affecting Pharmacy Students’ Decision to Study in Pharmacy Colleges in Saudi Arabia: A Cross-Sectional Questionnaire-Based Analysis." In Healthcare, vol. 9, no. 12, p. 1651. MDPI, 2021.
18. Almalki, Ziyad S., Ahmed Mohammed Alshehri, Latifah Abdullah Alturki, Rawan Abdullah Altamimi, Ahmed Abdulrahman Albassam, Maaly Salem Alqurashi, Feras Ahmed Saleh Al-Omaim, and Nehad Ahmed. "Exploring patient-safety culture in the community pharmacy setting: a national cross-sectional study." Postgraduate Medicine 133, no. 1 (2021): 57-65.
19. Ahmed, Nehad J., Mohamed A. Hassali, Ziyad S. Almalki, Abdullah U. Althemery, Mohammad Abdala, Hadeel Alahmadi, Abdul Hasseeb, and Amer H. Khan. "Prevalence and Antibiotic Resistance of Gram Negative and Gram Positive Bacteria in a Military Hospital in Riyadh Province." LATIN AMERICAN JOURNAL OF PHARMACY 40, no. 11 (2021): 2717-2721.
20. Alahmari, Abdullah Khaloofah, Ziyad Saeed Almalki, Abdul Hadi, Mohd Faiyaz Khan, Nehad Jaser Ahmed, Ahmed M. Alshehri, Abdulhadi Alqahtani, Areej Alshlowi, and Muhammad Shahid Iqbal. "Prevalence and Risk Factors for Medication Discrepancies on Hospital Discharge of Adult Diabetic Patients: A Prospective Single-center Cohort Study." LATIN AMERICAN JOURNAL OF PHARMACY 40, no. 11 (2021): 2655-2663.
21. Alqahtani AM, Almazrou SH, Alalweet RM, Almalki ZS, Alqahtani BF, AlGhamdi S. (2021).Impact of COVID-19 on Public Knowledge and Attitudes Toward Participating in Clinical Trials in Saudi Arabia: A Cross-Sectional Study. Int J Gen Med.14:3405-3413.
22. Iqbal, M. Z., Khan, A. H., Sulaiman, S. A. S., Iqbal, M. S., Alahmari, A. K., Almalki, Z. S., & Albassam, A. A. (2021). Impact of Pharmacist Educational Intervention on Predictors of Diabetic Retinopathy among Diabetic Patients at Two Tertiary Care Hospitals in Malaysia. Latin American Journal of Pharmacy, 40(4), 682-689.
23. Banseria, Ruchita, Mayank Shrivastava, Haradayal Meena, G. Meratwal, V. B. Singh, Y. Singh, I. Kazmi, F. A. Al-Abbasi, Z. S. Almalki, and M. F. Khan. (2021). Changes in Hematological Parameters by Quantifying HRCT Chest Results in Patients With COVID-19 in Tertiary Care Hospital. Alternative Therapies in Health and Medicine.27(12): AT6862.
24. Muhammad Zahid Iqbal,Amer Hayat Khan, Syed Azhar Syed Sulaiman, Muhammad Shahid Iqbal, Abdullah K. Alahmari, Ziyad S. Almalki, Ahmed A. Albassam, Salah-Ud-Din Khan, Javed Khan, Abdullah A. Alfaifi. (2021). Pharmacist-led Educational Interventions on Determinants of Diabetic Nephropathy among Diabetic Patients in Malaysia. Lat. Am. J. Pharm. 40 (5): 957-64.
25. Kajtazi NI, AlMalki Z, Tleyjeh I, Al-Naaim S, Al-Zailaie M, et al. (2021).Stroke Codes during the COVID-19 Pandemic: Clinical Characteristics. J Clin Neurol Neurosci ;2:13.
26. Almalki, Z. S. (2021). COVID-19’s Economic Impact on the Global Health Systems: Time to Respond to New Realities. Journal of Pharmaceutical Research International, 33(24A), 85-91.
27. Almalki, Z. S., Ahmed, N. J., Alahmari, A. K., Alshehri, A. M., Alyahya, S. A., Alqahtani, A., & Alhajri, M. (2021). Identifying the Risk Factors and the Prevalence of Poor Glycemic Control among Diabetic Outpatients in a Rural Region in Saudi Arabia. Journal of Pharmaceutical Research International, 15-23.
28. Ahmed, N. J., Almalki, Z. S., Haseeb, A., Hassali, A. A., & Khan, A. H. (2021). Review of the Appropriateness of Surgical Antimicrobial Prophylaxis. Journal of Pharmaceutical Research International, 81-92.
29. Simsim DA, Almalki ZS, Ahmed NJ. (2021). Current Practice of Using Technology in Health-care Delivery in Saudi Arabia: Challenges and Solutions. Asian Journal of Pharmaceutics. Mar 17;15(1).
30. Almalki, Z. S., Alqahtani, N., Salway, N. T., Alharbi, M. M., Alqahtani, A., el at. (2021). Evaluation of medication error rates in Saudi Arabia: A protocol for systematic review and meta-analysis. Medicine, 100(9), e24956.
31. Nehad Ahmad, Alaa Almansour, Abdulrahman Alrawili, Majed Alanzi, Omar Balabid, Faisal Alkhawaja, Ziyad Almalki.(2021). Previous Experience of Physicians with Antimicrobial Resistance and with the Implementation of Antimicrobial Stewardship Programs. Lat. Am. J. Pharm. 40 (2): 398-402.
32. Alahmari, A. K., Almalki, Z. S., Iqbal, M. S., Alossaimi, M. A., Alsaber, M. Z., Alanazi, R. A., ... & Salman, T. O. B. (2021). Knowledge and Attitude of Pharmacists about Biosimilar Medications in Saudi Arabia. International Journal of Pharmaceutical Investigation, 11(1), 123-126.
33. Ahmed NJ, Alkhawaja FZ, Alrawili AS, Almalki ZS. (2021). Public knowledge and attitudes toward COVID-19 Vaccination: A cross-sectional study. Medical Science,25(108), 279-284
34. Albassam, A. A., Alanazi, A., Alhaqbani, N., Alhoti, F., Almalki, Z. S., Alshehri, A. M., & Alzahrani, J. (2021). The potential of drug-herbal interaction among patients with chronic diseases in Saudi Arabia. Complementary Therapies in Clinical Practice, 101324.
35. Nehad J Ahmad1, Alaa Almansour, Bandar Al Matrafi, Ziyad S. Almalki.(2021). Patterns of Topical Gentamicin Prescribing and the Age and Gender Differences in its Prescribing in the Outpatient Setting. Lat. Am. J. Pharm. 40 (2): 334-8.
36. Ahmed NJ, Alkhawaja FZ, Alrawili AS, Almalki ZS. (2021). Public knowledge and attitudes toward COVID-19 Vaccination: A cross-sectional study. Medical Science, 25(108), 279-284.
37. Muhammad Shahid Iqbal, Atta Abbas Naqvi, Yaman Walid Kassab, Eldowaik Mohamed Salah Saad, Muhammad Zahid Iqbal, Tauqeer Hussain Mallhi, Fahad I. Al-Saikhan, Ziyad S. Almalki, Salah-Ud-Din Khan, Abdul Haseeb, Ahmed A. Albassam. (2020). Assessment of Effect of Warfarin Adherence on Health- Related Quality of Life among Warfarin Patients Using WHOQOL-BREF. Lat. Am. J. Pharm. 39 (11): 2285- 92.
38. Almalki, Z. S., Khan, M. F., Almazrou, S., Alanazi, A. S., Iqbal, M. S., Alqahtani, A., ... & Alahmari, A. K. (2020). Clinical Characteristics and Outcomes Among COVID-19 Hospitalized Patients with Chronic Conditions: A Retrospective Single-Center Study. Journal of multidisciplinary healthcare, 13, 1089.
39. Ahmed, N. J., Menshawy, M. A., Almalki, Z. S. (2020). Gender Differences in Prescribing Antihypertensive Drugs in a Public Hospital in Alkharj. Journal of Pharmaceutical Research International, 1-7.
40. Abdulhadi M. Alqahtani, Ziyad S. Almalki, Randah M. Alalweet, Saja H. Almazrou, Abdullah S. Alanazi, Mona A. Alanazi, Saleh Alghamdi. (2020). Assessing the severity of illness in patients with coronavirus disease in Saudi Arabia: A retrospective descriptive cross-sectional study. Front. Public Health | doi: 10.3389/fpubh.2020.593256.
41. Ahmed, N. J., Menshawy, M. A., Almalki, Z. S. (2020). Age-Related Prescribing Patterns of Antihypertensive Medications. Journal of Pharmaceutical Research International, 80-85.
42. Ahmed, N. J., Menshawy, M. A., Almalki, Z. S., & Alhajri, M. A. (2020). Age and Gender Trends in Prescribing and Utilization of Lipid-Lowering Drugs at a Public Hospital in Alkharj City. Journal of Pharmaceutical Research International, 32(27), 1-5.
43. Muhammad Zahid Iqbal, Ahmed A. Albassam, Ziyad S. Almalki, Salah-Ud-Din Khan, Muhammad Shahid Iqbal. (2020). Healthcare students’ perception about mental illnesses– A cross-sectional study. Medical Science, 24(106), 3835-3844.
44. Ahmed, N. J., Mangi, A. A., Menshawy, M. A., Almalki, Z. S., & Alhajri, M. A. (2020). An Assessment of Azithromycin Prescribed Interactions’ at the Outpatient Setting. Journal of Pharmaceutical Research International, 32(26), 102-107.
45. Almazrou, S.H., Almalki, Z.S., Alanazi, A.S., Alqahtani, A.M., AlGhamd, S.M., Comparing the impact of Hydroxychloroquine based regimens and standard treatment on COVID-19 patient outcomes: A retrospective cohort study. (2020). Saudi Pharmaceutical Journal.
46. Almalki, Z.S., Alshehri, A.M., Alturki, L.A., Altamimi, R.A., Albassam, A.A., Alqurashi, M.S., Saleh Al-Omaim, F.A. and Ahmed, N. (2020). Exploring patient safety culture in the community pharmacy setting: A national cross-sectional study. Postgraduate Medicine.
47. Ahmed, N., Almalki, Z. S., Alhajri, M., & Alharbi, A. (2020). An Evaluation of Acyclovir Prescribing Patterns in a Public Hospital in AlKharj. Journal of Pharmaceutical Research International, 32(27), 74-78.
48. Ziyad Saeed Almalki, Muhammad Shahid Iqbal, Manal Abdullah Alossaimi, Alwaleed Mohammed Lasaf, Bandar Abdullah Almawash, Fayez Hamoud Aldossary, Aliyah Mohammed Marghalani, Yazeed Abdulaziz Alsubaihi. (2020). Physicians’ Knowledge and Awareness about Biosimilars in Saudi Arabia: What is Imperative to Know ?? J Young Pharm. 12(3) : 280-284.
49. Ziyad S. Almalki , Muhammad Shahid Iqbal, Manal A. Alossaimi, Mohammed Zaid Alsaber , Raslan Abdullah Alanazi , Yazeed Mohammed Alruwaili , Saad Nashmi Altheiby , Thekra Omar Bin Salman. Pharmacists’ Awareness and Perceptions of Biosimilars in Saudi Arabia. (2020). Asian Journal of Pharmaceutics.
50. Abdullah K.Alahmari, Ziyad S. Almalki, Muhammad Shahid Iqbal, Manal A. Alossaimi, Alwaleed Mohammed Lasaf, Bandar Abdullah Almawash, Fayez Hamoud Aldossary, Aliyah Mohammed Marghalani, Yazeed Abdulaziz Alsubaihi. (2020). Evaluation of physicians’ practices, attitude and perceptions towards biosimilars usage among patients. Medical Science, 24(106), 4410-4417.
51. Almalki ZS, Simsim DA. The Role of Health Technology in Transforming Healthcare Delivery and Enhancing Spending Efficiency. 2020. Glob J Med Therap,2(3):11-15.
52. Ahmed, N., Elazab, E., Almalki, Z. S., & Alhajri, M. A. (2020). Exploring the Surgical Site Infection Rate after Caesarean Delivery in a Military Hospital in Alkharj. Journal of Pharmaceutical Research International, 32(27), 28-32.
53. Nehad J. Ahmed, Ziyad S. Almalki, Omar S. Alanazi, Abeer A. Alzahrani, Rana E. Alonazi, Ahmed M. Alshehri. (2020). Measures undertaken to avoid COVID-19 Infection: Internet-based, Cross-Sectional Survey Study. Asian Journal of Pharmaceutics, 14(4).
54. Iqbal, M.S., Kassab, Y.W., Al-Saikhan, F.I., Almalki, Z.S., Haseeb, A., Iqbal, M.Z. and Ali, M., 2020. Assessing quality of life using WHOQOL-BREF: A cross-sectional insight among patients on warfarin in Malaysia. Saudi Pharmaceutical Journal.
55. Almalki, Z. S., Albassam, A. A., Alhejji, N. S., Alotaibi, B. S., Al-Oqayli, L. A., & Ahmed, N. J. (2020). Prevalence, risk factors, and management of uncontrolled hypertension among patients with diabetes: A hospital-based cross-sectional study. Primary Care Diabetes. DOI:https://doi.org/10.1016/j.pcd.2020.02.004
56. Ziyad S. Almalki, Mohammed Shahid Iqbal, Faisal M. Alablan, Raed K. Alenazi, Abdullah R. Tasha, Mohammed F. Daghar, Naif M. Aldossary. (2020). Long Term Cost-Effectiveness of a Systolic Blood Pressure Goal of <120 mmHg in Hypertensive Patients Without Diabetes Mellitus. Value in Health Regional Issues, 21 (1), 157-163.
57. Yue, X., Pruemer, J. M., Hincapie, A. L., Almalki, Z. S., & Guo, J. J. (2019). Economic burden and treatment patterns of gynecologic cancers in the United States: evidence from the Medical Expenditure Panel Survey 2007–2014. Journal of Gynecologic Oncology, 31.
58. Almalki, Z., Alatawi, Y., Alharbi, A., Almaklefi, B., Alfaiz, S., Almohana, O., ... & Alanezi, A. (2019). Cost-Effectiveness of More Intensive Blood Pressure Treatment in Patients with High Risk of Cardiovascular Disease in Saudi Arabia: A Modelling Study of Meta-Analysis. International journal of hypertension, 2019.
59. Almalki, Z. S., Albassam, A. A., Alnakhli, M. A., Alnusyan, M. F., Alanazi, F. N., & Alqurashi, M. S. (2019). National rates of emergency department visits associated with diabetes in Saudi Arabia, 2011-2015. Annals of Saudi medicine, 39(2), 71-76.
60. Almalki, Z. S., Karami, N. A., Almsoudi, I. A., Alhasoun, R. K., Mahdi, A. T., Alabsi, E. A., Alotaib, T. M. (2018). Patient-centered medical home care access among adults with chronic conditions: National Estimates from the medical expenditure panel survey. BMC health services research, 18(1), 744.
61. Almalki, Z. S., Guo, J. J., Alahmari, A., Alotaibi, N., & Thaibah, H. (2018). Cost-Effectiveness of Simvastatin Plus Ezetimibe for Cardiovascular Prevention in Patients With a History of Acute Coronary Syndrome: Analysis of Results of the IMPROVE-IT Trial. Heart, Lung and Circulation, 27(6), 656-665.
62. Almalki, Z. S., Alotaibi, A. A., Alzaidi, W. S., Alghamdi, A. A., Bahowirth, A. M., & Alsalamah, N. M. (2018). Economic benefits of implementing patient-centered medical home among patients with hypertension. ClinicoEconomics and outcomes research: CEOR, 10, 665.
63. Almalki, Z. S., Yue, X., Xia, Y., Wigle, P. R., & Guo, J. J. (2017). Utilization, Spending, and Price Trends for Quinolones in the US Medicaid Programs: 25 Years' Experience 1991–2015. PharmacoEconomics-open, 1(2), 123-131.
64. Almalki, Z. S. (2017). Prevalence, Predictors, and Economic Impact of Drug-Drug Interaction Associated with Antipsychotic Medications among Adults in United States. value in health 20 (5), a294-a294
65. N Alotaibi, B Tyrrell, ZS Almalki, RA Mekary. (2017). A Comparison of Pituitary and Hypothalamic Hormones and Analogues Approved by the US Food and Drug Administration and Health Canada. value in health 20 (5), A179-A179
66. AK Alahmari, ZS Almalki, T Cavanaugh, JJ Guo, J Penm (2017). Direct and Indirect Economic Burden of Adults With Renal Failure: National US Estimates Using Medical Expenditure Panel Survey Data, 2008-2013. value in health 20 (5), A179-A179
67. Almalki, Z. S., Alahmari, A. K., Guo, J. J., & Cavanaugh, T. M. (2016). Off‐label use of oral fluoroquinolone antibiotics in outpatient settings in the United States, 2006 to 2012. Pharmacoepidemiology and drug safety, 25(9), 1042-1051.
68. Alahmari, A. K., Almalki, Z. S., Alahmari, A. K., & Guo, J. J. (2016). Thromboembolic events associated with bevacizumab plus chemotherapy for patients with colorectal cancer: a meta-analysis of randomized controlled trials. American health & drug benefits, 9(4), 221.
69. Almalki, Z. S. (2015). The use of low Molecular Weight Heparin and Pneumatic Compression Devises for Deep Vein Thrombosis Prophylaxis in Major Trauma Patients: A Comparative Effectiveness Analysis. value in health 20 (5), a294-a294.
70. Almalki, Z. S., & Guo, J. J. (2014). Cardiovascular events and safety outcomes associated with azithromycin therapy: a meta-analysis of randomized controlled trials. American health & drug benefits, 7(6), 318-28.
71. Z Almalki, JJ Guo, CM Kelton, PR Wigle (2013). Cost And Utilization Trends of Antiemetic Drug In Us Using Medicaid Database, 1991-2011. value in health 16 (3), A213.
72. Almalki Z, Guo JJ, Kelton CM, Wigle P (2013). Adverse events associated with colchicine drug interactions: Analysis of the public version of the FDA adverse event reporting system, 1991-2011. Value in Health 1 (6), A1-A298.
73. Almalki ZS et al, (2012) Access to orphan drugs in the Middle East: Challenge and perspective, Intractable and Rare Diseases Research 1(4), pp139-143.

Dr.Ziyad Saeed M Almalki

Education

Research Interests

Experience

Publications

Contact the university leaders

Administration of Public Relations and Media

Social

Faculty Members

Dr.Ziyad Saeed M Almalki

Education

Research Interests

Experience

Publications

Administration of Public Relations and Media